Project Grant HT94252510544
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$947K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The U.S. Department of Defense's Defense Health Agency awarded a $2,027,311 Project Grant to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from September 1, 2024, to August 31, 2028, will support advanced biomedical research focused on suicide prevention strategies for the National Guard. The...
The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...
The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
The University of Pennsylvania, through its Clinical Practices division, was awarded a $812,500 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting UGCG in the Melanoma Tumor Microenvironment." This 3-year research project, which commenced on September 1, 2024, aims to investigate innovative approaches to treating melanoma, a serious form of skin cancer, with a focus on modulating the tumor...
The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
This $390,000 Formula Grant was awarded on March 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research by The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to define oncogenic signaling networks and establish novel targets for lung adenocarcinoma therapy. The research aims to exploit synthetic essential genetic dependencies...
The Trustees of the University of Pennsylvania were awarded a $1.6 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research on Breast Cancer Recurrence: Mechanisms and Drivers being conducted in Philadelphia, PA from July 1, 2022 through June 30, 2025. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,178,136.00 to The Trustees of the University of Pennsylvania to conduct research on exploiting the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The research aims to transform healthcare for military service members and the broader public by advancing innovative approaches to disease...
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...